PubMed

Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report.

Kilby JM, Goepfert PA, Miller AP, Gnann JW Jr, Sillers M, Saag MS, Bucy RP.

Ann Intern Med. 2000 Sep 19;133(6):435-8. Review.PMID: 10975961 [PubMed - indexed for MEDLINE]Related articlesFree article

Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.

Staszewski S, Keiser P, Montaner J, Raffi F, Gathe J, Brotas V, Hicks C, Hammer SM, Cooper D, Johnson M, Tortell S, Cutrell A, Thorborn D, Isaacs R, Hetherington S, Steel H, Spreen W; CNAAB3005 International Study Team.

JAMA. 2001 Mar 7;285(9):1155-63. Erratum in: JAMA 2001 Jun 13;285(22):2858. PMID: 11231744 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.

Demeter LM, Hughes MD, Coombs RW, Jackson JB, Grimes JM, Bosch RJ, Fiscus SA, Spector SA, Squires KE, Fischl MA, Hammer SM.

Ann Intern Med. 2001 Dec 4;135(11):954-64.PMID: 11730396 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group.

Neumann AU, Tubiana R, Calvez V, Robert C, Li TS, Agut H, Autran B, Katlama C.

AIDS. 1999 Apr 16;13(6):677-83.PMID: 10397562 [PubMed - indexed for MEDLINE]Related articles

Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication.

Ioannidis JP, Havlir DV, Tebas P, Hirsch MS, Collier AC, Richman DD.

AIDS. 2000 Jul 28;14(11):1481-8.PMID: 10983634 [PubMed - indexed for MEDLINE]Related articles

Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus.

Wintergerst U, Hoffmann F, Sölder B, Notheis G, Petropoulou T, Eberle J, Gürtler L, Belohradsky BH.

Pediatr Infect Dis J. 1998 Jun;17(6):495-9.PMID: 9655541 [PubMed - indexed for MEDLINE]Related articles

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).

Squires KE, Gulick R, Tebas P, Santana J, Mulanovich V, Clark R, Yangco B, Marlowe SI, Wright D, Cohen C, Cooley T, Mauney J, Uffelman K, Schoellkopf N, Grosso R, Stevens M.

AIDS. 2000 Jul 28;14(11):1591-600.PMID: 10983646 [PubMed - indexed for MEDLINE]Related articles

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).

Eron JJ Jr, Murphy RL, Peterson D, Pottage J, Parenti DM, Jemsek J, Swindells S, Sepulveda G, Bellos N, Rashbaum BC, Esinhart J, Schoellkopf N, Grosso R, Stevens M.

AIDS. 2000 Jul 28;14(11):1601-10.PMID: 10983647 [PubMed - indexed for MEDLINE]Related articles

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.

Havlir DV, Hellmann NS, Petropoulos CJ, Whitcomb JM, Collier AC, Hirsch MS, Tebas P, Sommadossi JP, Richman DD.

JAMA. 2000 Jan 12;283(2):229-34.PMID: 10634339 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.

García F, Alonso MM, Romeu J, Knobel H, Arrizabalaga J, Ferrer E, Dalmau D, Ruiz I, Vidal F, Frances A, Segura F, Gomez-Sirvent JL, Cruceta A, Clotet B, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.

J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):26-35.PMID: 11064501 [PubMed - indexed for MEDLINE]Related articles

Prevalence and predictive value of intermittent viremia with combination hiv therapy.

Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, Collier AC, Hirsch MS, Ignacio C, Condra J, Günthard HF, Richman DD, Wong JK.

JAMA. 2001 Jul 11;286(2):171-9.PMID: 11448280 [PubMed - indexed for MEDLINE]Related articlesFree article

Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection.

Colven R, Harrington RD, Spach DH, Cohen CJ, Hooton TM.

Ann Intern Med. 2000 Sep 19;133(6):430-4.PMID: 10975960 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.

Gianotti N, Soria A, Galli L, Castagna A, Cernuschi M, Hasson H, Lazzarin A.

J Med Virol. 2004 Feb;72(2):181-6.PMID: 14695657 [PubMed - indexed for MEDLINE]Related articles

Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial).

Joly V, Flandre P, Meiffredy V, Brun-Vezinet F, Gastaut JA, Goujard C, Remy G, Descamps D, Ruffault A, Certain A, Aboulker JP, Yeni P; Novavir Study Group.

Antimicrob Agents Chemother. 2002 Jun;46(6):1906-13.PMID: 12019107 [PubMed - indexed for MEDLINE]Related articlesFree article

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

Descamps D, Flandre P, Calvez V, Peytavin G, Meiffredy V, Collin G, Delaugerre C, Robert-Delmas S, Bazin B, Aboulker JP, Pialoux G, Raffi F, Brun-Vézinet F.

JAMA. 2000 Jan 12;283(2):205-11. Erratum in: JAMA 2000 Sep 27;284(12):1518. PMID: 10634336 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.

Clark NM, Dieng Sarr A, Sankalé JL, Kanki PJ, Kazanjian P, Winfield R, Markovitz DM.

AIDS. 1998 Dec 24;12(18):2506-7. No abstract available. PMID: 9875594 [PubMed - indexed for MEDLINE]Related articles

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.

Wolbers M, Opravil M, von Wyl V, Hirschel B, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Battegay M, Yerly S, Günthard H, Bucher HC; Swiss HIV Cohort Study.

AIDS. 2007 Oct 18;21(16):2201-7.PMID: 18090047 [PubMed - indexed for MEDLINE]Related articles

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.

AIDS. 2008 Aug 20;22(13):1583-8.PMID: 18670217 [PubMed - indexed for MEDLINE]Related articles

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.

Gulick RM, Meibohm A, Havlir D, Eron JJ, Mosley A, Chodakewitz JA, Isaacs R, Gonzalez C, McMahon D, Richman DD, Robertson M, Mellors JW.

AIDS. 2003 Nov 7;17(16):2345-9.PMID: 14571186 [PubMed - indexed for MEDLINE]Related articles

Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.

Landay AL, Bettendorf D, Chan E, Spritzler J, Schmitz JL, Bucy RP, Gonzalez CJ, Schnizlein-Bick CT, Evans T, Squires KE, Phair JP.

AIDS Res Hum Retroviruses. 2002 Jan 20;18(2):95-102.PMID: 11839142 [PubMed - indexed for MEDLINE]Related articles